Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04716699 · ClinicalTrials.gov registry record · Phase 1
Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma
A Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT04716699 is a Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 12 participants.
The verdict
NCT04716699, a Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This clinical trial measures the amount and effect of lidocaine injected into patients with glioblastoma while they are undergoing surgical removal of their brain tumors. Lidocaine is a substance used to relieve pain by blocking signals at the nerve endings in skin. Information gained from this study may help researchers come up with new treatments to help patients with glioblastomas in the future.
Interventions
- PROCEDURE Biospecimen Collection
- DRUG Lidocaine
- PROCEDURE Resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-01-20 |
| Est. Completion | 2022-01-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04716699
The ClinicalTrials.gov registry entry for NCT04716699 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT04716699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04716699 about?
NCT04716699 is a clinical study titled "Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma". This clinical trial measures the amount and effect of lidocaine injected into patients with glioblastoma while they are undergoing surgical removal of their brain tumors. Lidocaine is a substance used to relieve pain by blocking signals at the nerve endings in skin. Information gained from this stud...
What is the current status of trial NCT04716699?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2021-01-20. Estimated completion is 2022-01-24.
What interventions are being tested in trial NCT04716699?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Lidocaine (DRUG), Resection (PROCEDURE).
Who is sponsoring clinical trial NCT04716699?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.